SJS Investment Consulting’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9K Buy
138
+125
+962% +$25.9K ﹤0.01% 682
2026
Q1
$2.92K Buy
13
+1
+8% +$249 ﹤0.01% 1180
2025
Q4
$2.89K Sell
12
-80
-87% -$20.5K ﹤0.01% 1059
2025
Q3
$25.2K Buy
92
+86
+1,433% +$23.5K ﹤0.01% 485
2025
Q2
$1.55K Sell
6
-3
-33% -$716 ﹤0.01% 654
2025
Q1
$2.02K Sell
9
-5
-36% -$1.17K ﹤0.01% 720
2024
Q4
$3.21K Sell
14
-3
-18% -$722 ﹤0.01% 539
2024
Q3
$4.16K Buy
17
+1
+6% +$223 ﹤0.01% 522
2024
Q2
$3.07K Hold
16
﹤0.01% 562
2024
Q1
$3.17K Buy
16
+5
+45% +$916 ﹤0.01% 574
2023
Q4
$1.89K Hold
11
﹤0.01% 690
2023
Q3
$1.63K Buy
11
+1
+10% +$181 ﹤0.01% 721
2023
Q2
$2.19K Buy
10
+3
+43% +$669 ﹤0.01% 571
2023
Q1
$1.53K Sell
7
-4
-36% -$868 ﹤0.01% 692
2022
Q4
$2.29K Sell
11
-2
-15% -$439 ﹤0.01% 578
2022
Q3
$3K Buy
+13
New +$2.96K ﹤0.01% 399
2022
Q1
$0 Buy
+2
New +$484 ﹤0.01% 1233

Other funds holding RMD

SJS Investment Consulting's RMD Position: Q2 2026 in Review

SJS Investment Consulting increased its ResMed (RMD) stake by 962% in Q2 2026, buying an estimated $25.9K and bringing the position to 138 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

SJS Investment Consulting first reported a position in RMD in Q1 2022 and has held it in 17 quarters since. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SJS Investment Consulting held 138 shares of ResMed worth $26.9K as of Q2 2026.
  • SJS Investment Consulting bought 125 ResMed shares in Q2 2026, an estimated $25.9K.
  • ResMed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #682 holding.
  • SJS Investment Consulting first reported a position in ResMed in Q1 2022 and has held it in 17 quarters since.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.